ABVC vs RMD · rev $796.0K vs P/E 29, rev $5.65B
ABVC Biopharma Inc (ABVC) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
ABVC currently screens at market cap $35.9M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the ABVC and RMD stock pages for the full models.
Not investment advice.